CIMZIATM (Certolizumab Pegol) Maintained Response And Remission In Crohn’s Patients Previously Treated With Infliximab

New data from a post hoc analysis of the PRECiSE clinical trial program demonstrated that the anti-TNF CIMZIATM (certolizumab pegol) maintained response and remission in patients with moderate to severe Crohn’s disease, regardless of whether or not they had been…

Read More

Survey Rates Hospital Safety, NEJM Examines Trend To Seek Medical Care Abroad

* “Leapfrog Hospital Quality and Safety Survey,” The Leapfrog Group: The survey evaluated 1,200 hospitals nationwide to determine the state of health care quality and safety in U.S. hospitals. Using the survey results, Leapfrog named 59 participating hospitals to the…

Read More

Cypher® Sirolimus-Eluting Coronary Stent Outperformed Taxus Stent In Long Coronary Lesions, New Trial

Results from a multicenter, prospective, randomized clinical trial indicate that the CYPHER® Stent performed better than the Taxus Stent in procedures involving long coronary lesions, which are considered some of the most complex blockages to treat with balloon angioplasty. The…

Read More